Diana Čekatauskaitė has an extensive background in business development, investment analysis, and life sciences management consulting. Diana currently holds the position of Associate Director, Business Development at Synaffix BV, a company that focuses on targeted cancer therapeutics. Diana previously worked at M Ventures and Arthur D. Little in business development and investment analysis roles. Diana also has experience in research as a Research Assistant at Karolinska Institutet and with the Molly Stevens group at Imperial College London. Diana holds a Master's degree in Medical Science with a Major in Bioentrepreneurship from Karolinska Institutet.
February, 2023 - present
January, 2022
October, 2020